Search Results
Search results for "GPCR data platform"
Results found for "GPCR data platform"
- Microbial Metabolites Orchestrate a Distinct Multi-Tiered Regulatory Network in the Intestinal Epith
Read more at the source #DrGPCR #GPCR #IndustryNews
- Inversago Pharma Completes Phase 1 Clinical Trial on First-in-Class, Peripheral CB1 Blocker and...
Read more at the source #DrGPCR #GPCR #IndustryNews
- Propranolol: A âPick and Rollâ Team Player in Benign Tumors and Cancer Therapies
Read more at the source #DrGPCR #GPCR #IndustryNews
- Why âDisplacementâ Misleads You: Allosteric Binding Demystified
Kenakinâs latest lecture delivers a wake-up call for pharmacologists interpreting allosteric binding data If your project involves GPCRs , functional selectivity , or non-traditional ligands , this session is If youâre still using orthosteric assumptions to interpret allosteric binding data, you're likely missing Subscribe to The Kenakin Brief today †#AllostericPharmacology #GPCR #BindingVsFunction #ReceptorPharmacology
- Structure Therapeutics Extends Financing, Advances Diabetes and Obesity Clinical Program and...
Read more at the source #DrGPCR #GPCR #IndustryNews
- Anatomy of a partnership: Cancer Research UK teams up with Sosei Heptares
Read more at the source #DrGPCR #GPCR #IndustryNews
- Dr. Ross Bathgate becomes Scientific co-founder of LASEREDD Therapeutics
position as Scientific co-founder LASEREDD Therapeutics" Ross Bathgate Read more at the source #DrGPCR #GPCR
- Professor Charlotte Deane Joins Exscientia as Chief Scientist of Biologics AI
Read more at the source #DrGPCR #GPCR #IndustryNews
- Addex Raises $10 Million In Equity Financing
Unregistered Warrants have an exercise price of $6.50 per ADS, will become exercisable in 60 days after their date of issuance and will expire six years from their date of issuance. Read more at the source #DrGPCR #GPCR #IndustryNews
- Jan Steyaert Named 2022 Jacob and Louise Gabbay Award Winner
Read more at the source #DrGPCR #GPCR #IndustryNews
- Sosei Heptares recently hosted their annual Scientific Advisory Board (SAB)
Read more at the source #DrGPCR #GPCR #IndustryNews
- Targeted Therapies to Reduce Side Effects in Modern Drug Development
Read more at the source #DrGPCR #GPCR #IndustryNews
- Regulation of rod photoreceptor function by farnesylated G-protein Îł-subunits
Read more at the source #DrGPCR #GPCR #IndustryNews
- Addex and Indivior Extend GABAB Positive Allosteric Modulator Research Collaboration for...
compounds for Charcot-Marie-Tooth type 1A neuropathy (CMT1A) and pain. " Read more at the source #DrGPCR #GPCR
- Karuna Therapeutics Announces Positive Results from Phase 3 EMERGENT-2 Trial of KarXT in...
Read more at the source #DrGPCR #GPCR #IndustryNews
- X4 slashes pipeline, lays off staff just three weeks after netting a $55M PIPE
Read more at the source #DrGPCR #GPCR #IndustryNews
- Platelets in the NETworks interweaving inflammation and thrombosis
Read more at the source #DrGPCR #GPCR #IndustryNews
- ÎČ2-Adrenergic Receptor Expression and Intracellular Signaling in B Cells Are Highly Dynamic during..
Read more at the source #DrGPCR #GPCR #IndustryNews
- Cancer Research UK and Sosei Heptares sign agreement to advance cancer immunotherapy candidate ...
Corporation (âthe Companyâ; TSE: 4565), an international biopharmaceutical company and world-leader in GPCR1 Read more at the source #DrGPCR #GPCR #IndustryNews
- Targeting the M1 muscarinic receptor in neurodegenerative disease
Translational Sciences Associate Director at Sosei Heptares, recently presented at the Keystone Symposia GPCR Read more at the source #DrGPCR #GPCR #IndustryNews
- Drug Discovery Pharmacology Principles That Turn Assays Into Real Medicines
Drug discovery programs rarely fail because an assay produced poor data. Pharmacologists interpret biological data. But chemists transform that data into molecules capable of becoming medicines. Your job as a pharmacologist is to guide them with solid data. teams navigating development bottlenecks scientific leaders seeking clear pharmacological guidance GPCR
- Domain Therapeutics Raises $42m Series A Financing
specializing in the research and development of innovative drugs targeting G Protein-Coupled Receptors (GPCRs Read more at the source #DrGPCR #GPCR #IndustryNews
- Effects of Small Molecule Ligands on ACKR3 Receptors
Read more at the source #DrGPCR #GPCR #IndustryNews
- Design Pharmaceuticals Closes $5 Million Pre-series A Round to Accelerate Commercialization of ...
$5 Million Pre-series A Round to Accelerate Commercialization of Ultrahigh Throughput Drug Discovery Platform The proceeds will be used to further build the companyâs discovery platform and operations. Design Pharmaceuticalsâ platform is based on ultrahigh-throughput technologies that biomine drug-like These molecules are then evaluated at unprecedented speed and scale on hundreds of GPCR targets simultaneously Read more at the source #DrGPCR #GPCR #IndustryNews
- Addex raises $4.2 million in equity financing
Unregistered Warrants have an exercise price of $1.90 per ADS, will become exercisable in 60 days after their date of issuance and will expire five years from their date of issuance. " Read more at the source #DrGPCR #GPCR #IndustryNews
- How Fast Does a Drug Work?
delivers exclusive, real-world insight designed to equip you to move beyond surface-level affinity data operational clarity and avoid wasted effort â The ability to reduce cycle times by recognizing when your data practical kinetic expertiseâcrafted to help drug hunters reduce wasted effort and move faster from data guidance on when to look deeper and how to extract meaningful, operational insight from your kinetic data s Corner  ______ #DrugDiscovery #Pharmacology #DrugKinetics #PipelineEfficiency #PharmaInnovation #GPCR
- Third Rock pushes newest fund over $1B line as it marks 15 years in venture capital
Read more at the source #DrGPCR #GPCR #IndustryNews
- Michel Bouvier appointed Knight of the Ordre national du Québec
Read more at the source #DrGPCR #GPCR #IndustryNews
- Crinetics Presents Clinical And Research Results At ENDO 2022
Read more at the source #DrGPCR #GPCR #IndustryNews
- Sosei Heptares Confirms Senior Leadership Changes to Drive the Company Through the Next Stage ...
Changes to Drive the Company Through the Next Stage of its Evolution "New team focused on expanding its GPCR-focused structure-based drug design platform and enhancing translational medicine capabilities âą âVenture-like Read more at the source #DrGPCR #GPCR #IndustryNews
